智翔金泰跌1.25% 连亏4年3季2023年上市募34.7亿

Core Viewpoint - Zhixiang Jintai (688443.SH) is currently experiencing a decline in stock price, having fallen to 29.23 yuan, representing a drop of 1.25%, and is in a state of breaking its initial public offering price [1] Group 1: IPO and Fundraising - Zhixiang Jintai was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on June 20, 2023, with an initial public offering of 91.68 million shares at a price of 37.88 yuan per share [1] - The total amount raised from the IPO was 3.472 billion yuan, with a net amount of 3.291 billion yuan after deducting issuance costs, which were 181.44 million yuan [1] - The actual net fundraising amount was 688.6 million yuan less than the originally planned amount of 4 billion yuan, which was intended for various projects including the construction of an antibody industrialization base and research and development of antibody drugs [1] Group 2: Financial Performance - Zhixiang Jintai has reported losses for four consecutive years and three quarters, with net profits attributable to shareholders of -322 million yuan in 2021, -576 million yuan in 2022, -801 million yuan in 2023, and -797 million yuan in 2024 [2] - For the first three quarters of 2025, the company achieved revenue of 208 million yuan, a significant increase of 1,562.05% year-on-year, but still reported a net loss of -333 million yuan attributable to shareholders [2] - The cash flow from operating activities was negative at -261 million yuan for the same period [2]